Thursday, 26 December 2013

Torrent Pharmaceuticals gets US FDA nod for Epilepsy drug Lamotrigine

Torrent Pharmaceuticals has received US Food and Drug Administration (US FDA) approval for Epilepsy drug Lamotrigine, a medicine which is used in partial epilepsy, bipolar disorder, generalised epilepsy, Lennox-Gastaut syndrome and absence seizures.

Torrent Pharmaceuticals is flagship company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.

No comments:

Post a Comment